Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas

British Journal of Cancer

Volumn 77, Issue 5, 1998, Pages 694-702

  Lacave, R ^a,b   Coulet, F ^a   Ricci, S ^a   Touboul, E ^b   Flahault, A ^b   Rateau, J G ^a   Cesari, D ^a   Lefranc, J P ^c   Bernaudin, J F ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL TENON   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Breast carcinoma; Chemoresistance; Glutathione S conjugate carrier; GSTp; MDR1; MRP; Reverse transcriptase polymerase chain reaction

Indexed keywords

MESSENGER RNA;

ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BIOPSY;

EID: 0031935431     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.115     Document Type: Article

References (61)

1. Abbaszadegan MR, Futcher BW, Klimecki WT, List A and Dalton W (1994) Analysis of multidrug resistance associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res 54: 4676-4679
2. Akiyama S, Fojo A, Hanover JA, Pastan I and Gottesman MM (1985) Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Som Cell Mol Genet 11: 117-126
3. Almquist KC, Lue DW, Hipfner DR, Mackie JE, Cole SPC and Deeley RG (1995) Characterization of the Mr 190,000 Multidrug Resistance Protein (MRP) in drug-selected and transfected human tumor cells. Cancer Res 55: 102-110
4. Alvarez M, Paull K, Monks A, Hose C, Lee JS, Weinstein J, Grever M, Bates S and Fojo T (1995) Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. J Clin Invest 95: 2205-2214
5. Areci RJ (1993) Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood 81: 2215-2222
6. Batist G, Tulpule A, Sinha BK, Katki AG, Myers CE and Cowan K.H (1986) Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem 261: 15544-15549
7. Beck WT, Grogan TM, Willman CT, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreeff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HSL, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Srivastava DK, Lehnert M, Leith CP, Paietta E, Pavelic ZP, Rimsza L, Roninson IB, Sikic BI, Twentyman PR, Warnke R und Weinstein R (1996) Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res 56: 3010-3020
8. Bénard JD, Silva JD, Blois MC, Boyer P, Duvillard P, Chiric E and Riou G (1985) Characterization of human ovarian adenocarcinoma line. IGROVI, in tissue culture and in nude mice. Cancer Res 45: 4970-4979
9. Breuninger LM, Paul S, Gaughan K, Miki T, Chan A, Aaranson SA and Kruh GD (1995) Expression of Multidrug Resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res 55: 5342-5347
10. Brotherick I, Shenton BK, Egan M, Cunliffe WE, Browell DA, Lunt LG, Young JR, Higgs MJ (1996) Examination of multidrug resistance in cell lines and primary breast tumours by flow cytometry. Eur J Cancer 32A: 2334-2341
11. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV and Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant cell line. Science 258: 1650-1654
12. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM and Deeley RG (1994) Pharmacological characterization of multi-drug resistant MRP-transfected human tumor cells. Cancer Res 54: 5902-5910
13. Coste A, Rateau JG, Roudot-Thoraval F, Chapelin C, Gilain L, Poron F, Peynegre R, Bernaudin JF and Escudier E (1996) Increased epithelial cell proliferation in nasal polyps. Arch Otolaryngol Head Neck Surg 122: 432-436
14. Charpin C, Vielh P, Duffaud F, Devictor B, Andrac L, Lavaut MN, Alasia C, Horschowski N and Piana L (1994) Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators. J Natl Cancer Inst 86: 1539-1545
15. Chevillard S, Pouillart P, Beldjord C, Asselain B, Beuzeboc P, Magdalena H and Vielh P (1996) Sequential assessment of multidrug resistance phenotype and measurement of S-Phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy. Cancer 77: 292-300
16. Endicott JA and Ling V (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58: 137-171
17. Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJL, Scheper RJ and Zaman GJR (1994) Immunochemical detection of the multidrug resistance associated protein MRP in human multidrug resistant tumor cells by monoclonal antibodies. Cancer Res 54: 4557-4563
18. Flens MJ, Zaman GJ, van der Valk P, Izquierdo MA, Schroeijers AB, Scheffer GL, van der Groep P, de Haas M, Meijer CJ and Scheper RJ (1996) Tissue distribution of the multidrug resistance protein. Am J Pathol 148: 1237-1247
19. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM and Pastan I (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84: 265-269
20. Gilbert L, Elwood LJ, Merino M, Masood S, Barnes R, Steinberg SM, Lazarous DF, Pierce L, D'Angelo T, Moscow JA, Townsend AJ and Cowan KH (1993) A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 11: 49-58
21. Gottesman MM and Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427
22. Gottesman MM, Goldstein LJ, Bruggemann E, Currier SJ, Galski H, Cardarelli C, Thiebaut F, Willingham MC and Pastan I (1989) Molecular diagnosis of multidrug resistance. Cancer Cells 7: 75-80
23. Gregorcyk S, Kang Y, Brandt D, Kolm P, Singer G and Perry RP (1996) P-Glycoprotein expression as a predictor of breast cancer recurrence. Ann Surg Oncol 3: 8-14
24. Hennequin E, Delvincourt C, Pourny C, Jardillier JC (1993) Expression of mdr1 gene in human breast primary tumors and metastases. Breast Cancer Res Treat 26: 267-274
25. Horikoshi T, Danenberg KD, Stadibauer THW, Volkenandt M, Shea LCC, Aigner K, Gustavsson B, Leichman L, Frösing R, Ray M, Gibson NW, Spears CP and Danenberg PV (1992) Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphoroase gene expression in human tumors using the polymerase chain reaction. Cuncer Res 52: 108-116
26. Ishikawa T, Akimaru K, Kuo MT, Priebe W and Susuki M (1995) How does the MRP/GS-X pump export doxorubicin? J Natl Cuncer Inst 87: 1639-1640
27. Jedlitschky G, Leier I, Buchholz U, Center M and Keppler D (1994) ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 54: 4833-4836
28. Keith WN, Stallard S and Brown R (1990) Expression of mdr1 and GSTpi in human breast tumours: comparison to in vitro chemosensitivity. Hr J Cancer 61: 712-716
29. Kuo MT, Bao J, Curley SA, Ikeguchi M, Johnston DA and Ishikawa T (1996) Frequent coordinated overexpression of the MRP/GS-X pump and g-glutamylcysteine synthetase genes in human colorectal cancers. Cancer Res 56: 3642-3644
30. Kruh GD, Gaughan KT, Godwin A and Chan A (1995) Expression pattern of MRP in human tissues and adult solid tumor cell lines. J Natl Cancer Inst 87: 1256-1258
31. Merkel DE, Fuqua SAW, Tandon AK, Hill SM, Buzdar AU and M Guire WI. (1989) Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. J Clin Oncol 7: 1129-1136
32. Morrow SC and Cowan KH (1993) Antineoplastic drug resistance and breast cancer. Ann NY Acad Sci 698: 289-312
33. Morrow CS, Cowan KH and Goldsmith ME (1989) Structure of the human genomic glutathione S-transferase-p gene. Gene 75: 3-11
34. Moscow JA, Townsend AJ, Goldsmith MH, Whang-Peng J, Vickers PJ, Poisson R, Legault-Poisson S, Myers CE and Cowan KE (1988) Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer. Proc Natl Acad Sci USA 85: 6518-6522
35. Moscow JA, Fairchild CR, Madden MJ, Random DT, Wieand HS, O'Brien EE, Poplack DG, Cossman J, Myers CK and Cowan KH (1989) Expression of anionic glutathione S transferase and P glycoprotein genes in human tissues and tumors. Cancer Res 49: 1422-1428
36. Müller M, Meijer C, Zaman GJR, Borst P, Scheper RJ, Mulder NH, D Vries EGE and Jansen PLM (1994) Overexpression of the gene encoding the multidrug resistance associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 91: 13033-13037
37. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, V Hoff DD and Roninson IB (1990) Quantitative analysis of MDRI (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160-7164
38. Nooter K, Westerman AM, Flens MJ, Zaman GJR, Scheper RJ, V Wingerden KE, Burger H, Oostrum R, Boersma T, Sonneveld P, Gratama JW, Kok T, Eggermont AMM, Bosman FT and Stoter G (1995) Expression of the multidrug resistance-associated Protein (MRP) gene in human cancers. Clin Cancer Res 1: 1301-1310
39. Nooter K, Brutel de la Rivière G, Klijn J, Stoter G and Foekens J (1997) Multidrug resistance protein in recurrent breast cancer. Lancet 349: 1885-1886
40. Ozcelik H, Mousses S and Andrulis IL (1995) Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAH1) in primary breast carcinomas wilh P53 mutations. Clin Cancer Res 1: 907-912
41. Pastan I and Gottesman M (1987) Multiple-drug resistance in human cancer. N Engl J Med 316: 1388-1393
42. Peters WH, Roelofs HM, van Putten WK, Jansen JB, Klijn JG and Foekens JA (1993) Response to adjuvant chemotherapy in primary breast cancer: no correlation wilh expression of glutathione S-transferases. Br J Cancer 68: 86-92
43. Ro J, Sahin A, Ro JY, Fritsche H, Hortobagyi G and Blick M (1990) Immunohistochemical analysis of P-glycoprotein expression correlated wilh chemotherapy resistance in locally advanced breast cancer. Hum Pathol 21: 787-791
44. Salmon SE, Grogan TM, Miller T, Scheper R and Dalton WS (1989) Prediction of doxorubicin resistance in vitro in myeloma, lymphoma and breast cancer by P-glycoprotein staining. J Natl Cancer Inst 81: 696-701
45. Sanfilippo O, Ronchi E, DeMarco C, DiFronzo G, and Silvestrini R (1991) Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine. Eur J Cancer 27: 155-158
46. Schneider WN, Bak M, Efferth TH, Kaufmann M, Marten J and Volm M (1989) P-glycoprotein expression in treated and untreated human breast cancer. Br J Cancer 60: 815-818
47. Shea TC, Clafin G, Comstock KE, Sanderson BJS, Burstein NA, Keenan EJ, Mannervick B and Henner WD (1990) Glutathione transferase activity and isoenzyme composition in primary human breast cancers. Cancel Res 50: 6848-6853
48. Silvestrini R, Veneroni S, Benini E, Daidone MG, Luisi A, Leutner M, Maucione A, Kenda R, Zucali R and Veronesi U (1997) Expression of p53 glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer. J Natl Cancer Inst 89: 639-645
49. Simon SM and Schindler M (1994) Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 91: 3497-3504
50. Slovak ML, Ho JP, Bhardwaj G, Kurz EU, Deeley RG and Cole SPC (1993) Localization of a novel multidrug resistance-associated gene in the HTI080/DR4 and H69AR human tumor cell lines. Cancer Res 53: 3221-3225
51. Soule HD, Vazquez A, Long A, Albert S and Brennan M (1973) Human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1413
52. Tew KD (1994) Glutathione-associated enzymes in anticancer drug resistance. Cancel Res 54: 4313-4320
53. van Kalken CK, Pinedo HM and Giaccone G (1991) Multidrug resistance from the clinical point of view. Eur J Cancer 27: 1481-1486
54. Verrelle P, Messonier F, Fonck Y, Feillel V, Dionet C, Kwiatkoswski F, Plagne R and Chassagne J (1991) Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl Cancer Inst 83: 111-116
55. Wallner J, Despich D, Hopfner M, Haider K, Spona J, Ludwig H and Pirker R (1991) MDR 1 gene expression and prognostic factors in primary breast carcinomas. Eur J Cancer 27: 1352-1355
56. Weinstein RS, Kuszak JR, Kluskens LF and Coon JS (1990) P-glycoproteins in pathology: the multidrug resistance gene family in humans. Human Pathol 21: 34-48
57. Wishart GC, Plumb JA, Going JJ, M Nicol AM, M Ardle CS, Tsuruo P and Kaye SB (1990) P-glycoprotein expression m primary breast cancer detected by immunocytochemistry with two monoclonal antibodies. Br J Cancer 62: 758-761
58. Zaman GJR, Versantvoort CHM, Smit JJM, Eijdems EWHM, d Haas M, Smith AJ, Broxterman HJ, Mulder NH, d Vries EGE, Baas F and Borst P (1993) Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53. 1747-1750
59. Zaman GJR, Flens MJ, V Leusden MR, D Haas M, Mulder NH, Lankelma J, Pinedo J, Scheper HM, Baas RJ, Broxterman HJ and Burst P (1994) The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91: 8822-8826
60. Zaman GJR, Lankelma J, V Tellingen O, Beijnen J, Dekker H, Paulusma C, Elferink RPJO, Baas RJ and Borst P (1995) Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 92: 7690-7694
61. Zijlstra JG, D Vries EGE and Mulder NH (1987) Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 47: 1780-1784